Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Cholesterol modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Cloudbreak Therapeutics LLCStartup |
Active Organization Cloudbreak Therapeutics LLCStartup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Meibomian Gland Dysfunction | Phase 2 | US | Cloudbreak Therapeutics LLCStartup | 05 Sep 2021 |
Phase 2 | 92 | (CBT-006 Lower Concentration) | xmlnisyoed(mezylwqrem) = gybozvsrph yqmcscjftb (lajghpkpee, bykqvhzecy - cdzbuohgvf) View more | - | 24 Apr 2024 | ||
(CBT-006 Higher Concentration) | xmlnisyoed(mezylwqrem) = qmsmisfoim yqmcscjftb (lajghpkpee, kmfirudxsl - iulzvtpits) View more |